Working... Menu

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03755804
Recruitment Status : Recruiting
First Posted : November 28, 2018
Last Update Posted : July 11, 2019
Teva Pharmaceuticals USA
Seattle Genetics, Inc.
Information provided by (Responsible Party):
St. Jude Children's Research Hospital

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : January 1, 2027
  Estimated Study Completion Date : July 1, 2028